Schedule 13G ownership disclosure

Benitec Biopharma LTD/ADR

Security class unavailable · CUSIP: 082053307

Event date: 2018-04-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,444,020
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-18-002151
Form type
SC 13G
Filer
Benitec Biopharma LTD/ADR
CIK
CIK 1552795
Filed
May 09, 2018
Reporting period
Apr 30, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub